Replies to post #6531 on International Stem Cell Corp. (ISCO)

[236T568]

So is that why scam company ISCO has been avoiding clinical trials in the U.S. and now conducting them in other countries like Australia?

https://www.otcmarkets.com/stock/ISCO/news/International-Stem-Cell-Corporation-Completes-Enrollment-and-Dosing-in-its-Parkinsons-Disease-Clinical-Trial?id=226152

Correct... It's an article, not a press release. I first saw this on the FDA site. But, it's still unrelated to ISCO since different types of stem cells are used along with different methods.

Just like not all tech is the same. Not all stem cells are the same.

ISCO has a type of stem cell technology that should eliminate most issues facing stem cell companies. It's a tough nut to crack since most stem cell therapies cause enough harm that they are too risky.... that's why so many are out of business. Go to ISCO site and read about how they derive their stem cells.

It will be interesting to see final results of the Parkinson trial.

Dilution has been the main problem here.